Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data
Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...
Bernstein reiterates Eli Lilly stock Outperform with $1,100 target
Bernstein research firm maintained a positive outlook on Eli Lilly (NYSE:LLY) shares, reiterating an Outperform rating and a ...
Yahoo Finance4d
Tectonic Therapeutic, Inc. (TECX)
Tectonic recently announced its third-quarter 2024 financial results, highlighting signif Phase 1a results support further development of TX000045 (“TX45”) for Group 2 Pulmonary Hypertension i ...
Piper Sandler Reaffirms Their Buy Rating on Tectonic Therapeutic (TECX)
In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Tectonic Therapeutic (TECX – Research Report), with a ...
Yahoo Finance5d
Tectonic Therapeutic, Inc. (TECX)
After hours: February 6 at 4:38:44 p.m. EST ...